Search
for
Sort by
Research 781–810 of 1000+
- Evaluation and treatment of male and female pattern hair loss
- Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi
- Activity of 17β-(N-Alkyl/arylformamido) and 17β-[(N-Alkyl/aryl) alkyl/arylamido]-4-methyl-4-aza-5α-androstan-3-ones as 5α-Reductase Inhibitors in the Hamster Flank Organ and Ear11The research has been supported by Endorecherche that is seeking patent protection for the new compounds. F. Labrie is President of Endorecherche.
- Trends in Nanotechnology for Practical Applications
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- Emulgel Considered as Anovel Type of Dosage Form for Topical Application
- Skin manifestations of hyperandrogenism: an update
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- A machine learning and network framework to discover new indications for small molecules
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Rat hair-follicle-associated pluripotent (HAP) stem cells can differentiate into atrial or ventricular cardiomyocytes in culture controlled by specific supplementation
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- From Nature to Follicle: Controlled Infusion-Based Polyherbal Hair Growth Oil — Bioactive Characterization and Dermatological Safety Profiling
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Immune therapies for alopecia areata: evidence and new perspectives
- Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Alopecia Areata: An Updated Review for 2023
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Stem cell-based therapies for alopecia areata: a narrative review
- Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Bicalutamide in Dermatology: A Narrative Review